Humana (HUM) Projected to Post Quarterly Earnings on Wednesday

Humana (NYSE:HUM) is expected to be announcing its Q1 2026 results before the market opens on Wednesday, April 29th. Analysts expect the company to announce earnings of $10.00 per share and revenue of $39.0839 billion for the quarter. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Parties may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Wednesday, April 29, 2026 at 8:00 AM ET.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. The business had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business’s quarterly revenue was up 11.3% on a year-over-year basis. During the same period in the prior year, the firm posted ($2.16) earnings per share. On average, analysts expect Humana to post $9 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Humana Stock Performance

Shares of HUM stock opened at $215.26 on Monday. The business’s fifty day simple moving average is $184.64 and its 200-day simple moving average is $228.15. The company has a market cap of $25.84 billion, a PE ratio of 21.92, a PEG ratio of 2.31 and a beta of 0.44. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. Humana has a 12-month low of $163.11 and a 12-month high of $315.35.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio is presently 36.05%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Morgan Stanley set a $146.00 price target on Humana in a research report on Thursday, February 12th. Barclays cut their price target on Humana from $245.00 to $176.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 24th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $344.00 price target on shares of Humana in a research report on Tuesday, January 6th. Jefferies Financial Group cut their price target on Humana from $310.00 to $235.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Finally, UBS Group reaffirmed a “neutral” rating on shares of Humana in a research report on Wednesday, February 25th. Seven analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat, Humana has an average rating of “Hold” and a consensus price target of $222.09.

Insiders Place Their Bets

In related news, insider Sanjay K. Shetty purchased 810 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the purchase, the insider owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This represents a 7.47% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of HUM. Larson Financial Group LLC lifted its stake in Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares in the last quarter. Fulcrum Asset Management LLP acquired a new stake in shares of Humana during the 3rd quarter worth approximately $42,000. DV Equities LLC acquired a new stake in shares of Humana during the 4th quarter worth approximately $43,000. BOKF NA increased its holdings in shares of Humana by 4,125.0% during the 3rd quarter. BOKF NA now owns 169 shares of the insurance provider’s stock worth $44,000 after buying an additional 165 shares during the last quarter. Finally, Caden Capital Partners LP acquired a new stake in shares of Humana during the 4th quarter worth approximately $112,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.